Dow Corning provides performance-enhancing solutions to serve the diverse needs of more than 25,000 customers worldwide. A global leader in silicon-based technology and innovation, offering more than 7,000 products and services, Dow Corning is equally owned by The Dow Chemical Company and Corning Incorporated. More than half of Dow Corning’s sales are outside the United States.

Crucell & DSM strengthen & expand development of PER.C6 Protein & Monoclonal Antibody Licensing Business

20 December 2005 - Dow Corning Silanes Dutch biotechnology company Crucell N.V. and DSM Biologics, a Pharmaceutical Products' business unit of Royal DSM NV announced today that they will strengthen and expand the development of the PER.C6 protein and monoclonal antibody business. The two companies will create an integrated solution for production of recombinant proteins and monoclonal antibodies on PER.C6 in order to increase licensing and royalty income and accelerate the development and role out of the PER.C6 technology platform in the market.

Dow Corning launches Silanes web site

25 August 2004 - Dow Corning Silanes Dow Corning launches Silanes web site which provides product application, solutions information

Dow Corning names solutions centre manager

18 June 2004 - Dow Corning Silanes Dow Corning names solutions centre manager, who will oversee surface and interface solutions center;expand silanes innovation expertise

Innovative composites expected from new solutions centre

26 May 2004 - Dow Corning Silanes Dow Corning Corporation has established a new global research center to pioneer the development of innovative technologies and applications for organosilane and silicon-containing chemicals.

Dow Corning announces increase in silanes capacity

08 December 2003 - Dow Corning Silanes Dow Corning Corporation has announced it has increased production of its broad range of silane coupling agents by more than 40 percent to better satisfy customer demand.